DOK4/IRS-5 expression is altered in clear cell renal cell carcinoma

International Journal of Cancer

Volumn 121, Issue 5, 2007, Pages 992-998

  Al Sarraf, Nael ^a   Reiff, Johanne Nørvig ^b   Hinrichsen, Jane ^b   Mahmood, Shaukat ^b   Teh, Bin Tean ^c   McGovern, Eilish ^a   De Meyts, Pierre ^b   O'Byrne, Kenneth J ^a   Gray, Steven G ^a,b  

^a ST JAMES S HOSPITAL   (Ireland)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Chromatin; Epigenetics; Insulin receptor substrate; Renal cell carcinoma

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 5; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; UPREGULATION;

ACETYLATION; BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL LINE; DNA PROBES; EVOLUTION, MOLECULAR; FEMALE; HISTONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34547110128     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22776     Document Type: Article

References (36)

1. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005;353:2477-90.
2. Takahashi M, Rhodes DR, Furge KA, Kanayama HO, Kagawa S, Haab BB, Teh BT. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001;98:9754-9.
3. Gettman MT, Blute ML. Update on pathological staging of renal cell carcinoma. Urology 2002;60:209-17.
4. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 1999;154:981-6.
5. Tan MH, Rogers CG, Cooper JT, Ditlev JA, Maatman TJ, Yang X, Furge KA, Teh BT. Gene expression profiling of renal cell carcinoma. Clin Cancer Res 2004;10:6315S-21S.
6. Stassar MJJG, Devitt G, Brosius M, TRinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A, Zöller M. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 2001;85:1372-82.
7. Kellner R, Lichtenfels R, Atkins D, Bukur J, Ackermann A, Beck J, Brenner W, Melchior S, Seliger B. Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance. Proteomics 2002;2:1743-51.
8. Gerritsen ME, Peale FVJ, Wu T. Gene expression profiling in silico: relative expression of candidate angiogenesis associated genes in renal cell carcinomas. Exp Nephrol 2002;10:114-9.
9. Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN, Gray SG, Knapp R, Anema J, Kahnoski R, Nicol D, Vogelzang NJ, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003;22:6810-8.
10. Gray SG, Stenfeldt Mathiasen I, De Meyts P. The Insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy? Horm Metab Res 2003;35:857-71.
11. Hammerman MR. The growth hormone-insulin-like growth factor axis in kidney re-revisited. Nephrol Dial Transplant 1999;14:1853-60.
12. Richmond EJ, Uzri A, Rogol AD. The Insulin-like growth factor system in kidney diseases. Nephron 2001;89:5-9.
13. Hintz RL, Bock S, Thorsson AV, Bovens J, Powell DR, Jakse G, Petrides PE. Expression of the insulin ike growth-factor-binding protein 3 (IGFBP-3) gene is increased in human renal cell carcinomas. J Urol 1991;146:1160-3.
14. Cheung C, Vesey D, Cotterill A, Douglas M, Gobe G, Nicol D, Johnson D. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas. Int J Urol 2005;12:17-28.
15. Takahashi M, Papavero V, Yuhas J, Kort E, Kanayama HO, Kagawa S, Baxter RC, Yang XJ, Gray SG, Teh BT. Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol 2005;26:923-31.
16. Kellerer M, von Eye CH, Muhlhofer A, Capp E, Mosthaf L, Bock S, Petrides PE, Haring HU. Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer 1995;62:501-7.
17. Ahmad N, Keehn CA, Coppola D. The expression of insulin-like growth factor-I receptor correlates with Fuhrman grading of renal cell carcinomas. Hum Pathol 2004;35:1132-6.
18. Parker A, Cheville JC, Lohse C, Cerhan JR, Blute ML. Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma. J Urol 2003;170:420-4.
19. Parker AS, Cheville JC, Janney CA, Cerhan JR. High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal carcinomas. Hum Pathol 2002;33:801-5.
20. Schips L, Zigeuner R, Ratschek M, Rehak P, Ruschoff J, Langner C. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma. Am J Clin Pathol 2004;122:931-7.
21. Lee YH, White MF. Insulin receptor substrate proteins and diabetes. Arch Pharm Res 2004;27:361-70.
22. Cai D, Dhe-Paganon S, Melendez PA, Lee J, Shoelson SE. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem 2003;278:25323-30.
23. Favre C, Gerard A, Clauzier E, Pontarotti P, Olive D, Nunes JA. DOK4 and DOK5: new Dok-related genes expressed in human T cells. Genes Immun 2003;4:40-5.
24. Bedirian A, Baldwin C, Abe J, Takano T, Lemay S. Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells. J Biol Chem 2004;279:19335-49.
25. Itoh S, Lemay S, Osawa M, Che W, Duan Y, Tompkins A, Brookes PS, Sheu SS, Abe J. Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells. J Biol Chem 2005;280:26383-96.
26. Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003;162:925-32.
27. Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;5:150-63.
28. Kuhn RM, Karolchik D, Zweig AS, Trumbower H, Thomas DJ, Thakkapallayil A, Sugnet CW, Stanke M, Smith KE, Siepel A, Rosenbloom KR, Rhead B, et al. The UCSC genome browser database: update 2007. Nucleic Acids Res 2007;35:D668-D73.
29. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31.
30. Crowder RJ, Enomoto H, Yang M, Johnson EM, Jr, Milbrandt J. Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth. J Biol Chem 2004;279:42072-81.
31. Bjornholm M, He AR, Attersand A, Lake S, Liu SC, Lienhard GE, Taylor S, Arner P, Zierath JR. Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 2002;45:1697-702.
32. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006;31:89-97.
33. Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol 2006;310:251-74.
34. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005;2 (Suppl 1):S4-S11.
35. Liu ZJ, Lu X, Zhang Y, Zhong S, Gu SZ, Zhang XB, Yang X, Xin HM. Downregulated mRNA expression of ASPP and the hypermethylation of the 5′-untranslated region in cancer cell lines retaining wild-type p53. FEBS Lett 2005;579:1587-90.
36. Nagle JA, Ma Z, Byrne MA, White MF, Shaw LM. Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol 2004;24:9726-35.